Key Highlights

  • HWKN is trading down 0.95% at $129.75 on October 21, with a market capitalization of about $2.71 billion.
  • Fiscal second-quarter results are due Monday, October 26, for the quarter ended September 27.
  • Fiscal first-quarter revenue was $315.7 million, up 8%, and EPS was $1.35 against $1.40.
  • First-quarter gross margin was 23%, down from 25% a year earlier.
  • Trailing EPS is $3.87, the P/E is 33.56 and the dividend yield is 0.59%.

Will Acquisitions Matter More Than Chemical Prices When Hawkins Reports?

Hawkins (NASDAQ:HWKN) is trading down 0.95% at $129.75 on October 21, and no company announcement was identified for the session. The company said in an October 5 release that it will report fiscal second-quarter results, for the quarter ended September 27, on Monday, October 26.

The question is whether volume from recent acquisitions can outweigh pricing and cost pressure on chemicals. The company bought Dave Symonds and Associates in Florida on September 1 and Eagle Labs in the Dallas-Fort Worth area on September 29, so their contribution this quarter is limited to a short period and a fuller contribution would come in later quarters.

Hawkins distributes specialty chemicals and ingredients for water treatment, industrial uses, and health and nutrition. Its market capitalization is about $2.71 billion.

What Did the First-Quarter Call Set Up?

In fiscal first quarter, ended June 28, revenue rose 8% to $315.7 million, with organic growth of about 5%. Net income was $28.3 million, or $1.35 per share against $1.40 a year earlier, and adjusted EBITDA rose 1% to $56.9 million. Operating cash flow was $35.2 million and free cash flow was $23.5 million.

Water treatment sales rose 6% to $158.3 million at a steady 29% gross margin, including $6.9 million from acquired businesses. Food and health sciences sales rose 9% to $97.3 million, with agricultural products up 30% and food ingredient volumes lower. A third segment grew 10% to $60.1 million, but its gross margin slipped to 15% from 17%.

Gross margin overall fell to 23% from 25%, pressured by a larger inventory cost reserve increase of $1.9 million and about $1.3 million of unrecovered freight. Management said raw material costs had largely stabilized by quarter-end and expects organic growth to return to historical rates in fiscal 2027, with continued debt paydown from leverage of 1.36 times.

What Would a Good or Bad Quarter Look Like for Hawkins?

Positive signals would be organic growth near or above the 5% pace, gross margin recovering toward the prior-year 25%, and visible contribution from acquired businesses. Management commentary on how the new Texas and Florida operations are being integrated would also matter, since they are small relative to a $2.71 billion market capitalization.

Negative signals would be chemical price deflation passing through to revenue, further margin compression or EPS below the $1.35 earned in the first quarter. These are the readings investors will look for and not predictions.

What Should Investors Track After the Monday Report?

Trailing EPS is $3.87 with a trailing P/E of 33.56, and trailing EPS growth of negative 4.79% reflects the year-over-year dip in recent results. The consensus analyst rating is Buy, and Barclays lowered its price target in mid-October to $141 from $142, a data point. The quarterly dividend of $0.19 gives a 0.59% yield. After the report, investors will follow gross margin, water treatment volumes, the pace of acquisitions and any update on the fiscal 2027 growth outlook.